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Parkinson’s disease has been associated with the selective loss of neurons in the
substantia nigra pars compacta. Increasing evidence suggests that oxidative stress plays
a major role. The resulting increase in reactive oxygen species triggers a sequence of
events that leads to cell damage, activation of microglia cells and neuroinflammatory
responses. Our objective was to study whether chronic exposure to low doses of ozone,
which produces oxidative stress itself, induces progressive cell death in conjunction with
glial alterations in the substantia nigra. Animals were exposed to an ozone-free air stream
(control) or to low doses of ozone for 7, 15, 30, 60, or 90 days. Each group underwent
(1) spectrophotometric analysis for protein oxidation; (2) western blot testing for microglia
reactivity and nuclear factor kappa B expression levels; and (3) immunohistochemistry for
cytochrome c, GFAP, Iba-1, NFkB, and COX-2. Our results indicate that ozone induces
an increase in protein oxidation levels, changes in activated astrocytes and microglia,
and cell death. NFkB and cytochrome c showed an increase until 30 days of exposure,
while cyclooxygenase 2 in the substantia nigra increased from 7 days up to 90 days of
repetitive ozone exposure. These results suggest that oxidative stress caused by ozone
exposure induces changes in inflammatory responses and progressive cell death in the
substantia nigra in rats, which could also be occurring in Parkinson’s disease.
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Introduction
In densely populated areas, higher ozone (O3) concentrations exist, inducing measurable transient
changes in lung function and airway inflammation, aggravating pre-existing respiratory diseases
such as asthma and resulting in excess mortality. In adults and children, the potential effects of
ozone exposure include encephalopathic signs and central nervous system symptoms, cognitive
effects, increased blood pressure and reduced measures of intelligence (Genc et al., 2012). Several
reports have suggested that these types of symptoms could be produced by an altered redox state.
However, the effect of exposure to low doses of ozone in specific areas of the brain has not been
thoroughly studied.
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Redox balance is necessary for the maintenance of homeosta-
sis in organisms because redox signals participate in the regula-
tion of many cellular pathways (Adibhatla and Hatcher, 2010).
The loss of the oxidation-reduction balance causes an oxidative
stress state; this state is characterized by an increase in pro-
oxidants and a decrease in the capacity of the antioxidant sys-
tem to resist the effects of the reactive oxygen species (ROS)
and reactive nitrogen species (RNS) (Rivas-Arancibia et al., 2010;
Halliwell, 2012). This is very important because in the chronic
oxidative stress state, alterations of redox signaling incite the loss
of regulatory pathways. Some examples of these alterations have
been reported, including obstruction of the antioxidant system,
alterations in the immune system, dysregulation of inflammatory
responses, changes in the cellular cycle, and the loss of neuronal
repair mechanisms (Rivas-Arancibia et al., 2010).
Moreover, loss of the mechanisms that control oxide reduc-
tion produces alterations in the physiological responses involved
in the repair of tissue damage in addition to all of the previous
changes, such as the oxidation of biomolecules, nucleic acids,
proteins, lipids, and carbohydrates. These changes also con-
tribute to mitochondrial alterations and cell death (Rodríguez-
Martínez et al., 2013). Consequently, oxidative stress has been
implicated in the pathophysiology of many neurodegenerative
diseases and aging (Fukagawa et al., 2000; Luo and Roth, 2000;
Dorado-Martínez et al., 2001; Hsieh and Yang, 2013; Rodríguez-
Martínez et al., 2013).
Ozone is the result of photochemical air pollution, and higher
concentrations are reported in more densely populated cities.
When ozone is inhaled, it produces ROS, and this overproduc-
tion of ROS could affect the nervous systems in two distinct ways.
The first is by affecting the olfactory bulb and brain tissue directly
(Colín-Barenque et al., 1999); and the second is through the res-
piratory system, where it overwhelms the antioxidant defense
system of the lungs in a dose-dependent manner. Finally, the
ROS and RNS that are secondarily produced by ozone expo-
sure can then reach the central nervous system (CNS) through
the bloodstream, producing oxidative stress, (Dorado-Martínez
et al., 2001) cellular damage (Angoa-Pérez et al., 2006; Pereyra-
Muñoz et al., 2006) and increased lipid peroxidation in vari-
ous brain structures (Rivas-Arancibia et al., 2000, 2003). Ozone
has also been demonstrated to produce functional changes and
cumulative structural damage in rats and monkeys exposed to
O3 at levels similar to those found in currently occurring ambi-
ent peaks. Indeed, some previous reports have indicated that
humans are likely to be more sensitive to O3 than rats (Lipp-
mann, 1989). In addition, previous studies have reported that
chronic exposure to ozone causes neurodegeneration in the stria-
tum and substantia nigra after 30 days of exposure to 0.25 ppm
ozone (Pereyra-Muñoz et al., 2006). The substantia nigra and
striatum are particularly vulnerable to oxidative stress because
normal dopamine metabolism involves many oxidative reac-
tions (Hermida-Ameijeiras et al., 2004). Moreover, ozone expo-
sure increases the production of dopamine quinones, oxidative
metabolites of dopamine, and the inactivation of antioxidant sys-
tems (Rosengren et al., 1985). Ozone exposure also alters redox
signals, which contributes to the increase of oxidative stress
(Santiago-López et al., 2010) and the activation of pathways that
cause dopaminergic neuronal death (Pereyra-Muñoz et al., 2006).
Damage and cellular death contribute to an increase in oxidative
stress and the inflammatory response, which cause alterations in
the blood-brain barrier (Mosley et al., 2006). Dopamine oxida-
tion has a direct correlation with dopaminergic neuronal death
in the substantia nigra (Santiago-López et al., 2010).
We developed a noninvasive animal model of the oxida-
tive stress state by exposing rats to daily low doses of ozone
(0.25 ppm). We have previously reported that ozone causes pro-
gressive neurodegeneration depending on the dose of chronic
exposure to this gas (4).
Our aim was to determine if chronic and repetitive
exposure to low doses of ozone causes oxidative stress, pro-
gressive neurodegeneration and dysregulation of inflammatory
responses.
Materials and Methods
Animals and Animal Care
Seventy-two (72) male Wistar rats, weighing 250–300 g, were
individually housed in acrylic boxes with food provided ad libi-
tum (NutriCubo, Purina, USA). Acrylic boxes were kept in a
clean-air box. Both the control and treated rats were main-
tained in a temperature- and humidity-controlled environmen-
tal bioterium. The animals were kept and treated in accor-
dance with the Norma Official Mexicana NOM-036-SSA 2-
2002, the National Institutes of Health Guidelines for Ani-
mal Treatment and the ethical committee of the faculty of
Medicine at the National Autonomous University of Mex-
ico.
General Procedures
Rats were randomly divided into six experimental groups (n =
12 per group). Group 1 was composed of animals exposed daily
to a clean air stream free of O3for 4 h, and groups 2, 3, 4, 5, and 6
were animals exposed for 7, 15, 30, 60, and 90 days, respectively,
to O3. The experimental groups were exposed daily to 0.25 ppm
ozone for 4 h. (Halliwell, 2012)
O3 Exposure
Each day, animals were placed inside a chamber with a diffuser
connected to a variable flux ozone generator (5 L/s) for 4 h. The
procedure used has been previously described (Pereyra-Muñoz
et al., 2006; Rivas-Arancibia et al., 2010). Previously filtered air
was used by the ozone generator to produce ozone. Ozone pro-
duction levels were proportional to current intensity and air
flux. A PCI Ozone and Control System Monitor (W. Caldwel-
N.J., USA) was used to measure the ozone concentration inside
the chamber throughout the experiment and to keep the ozone
concentration constant.
A similar chamber was used for the control group, for which
ozone-free air was administered for 30 days.
Two hours after the last exposure to clean air or O3, animals
from each group were deeply anesthetized with sodium pento-
barbital (50mg/kg i.p.; Sedalpharma, Edo. de México, México)
and killed by decapitation. Samples of plasma were obtained
for spectrophotometry assays. Finally, the substantia nigra of six
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animals from each group were obtained for western blot, and
the other six animals from each group were transcardially per-
fused with 4% paraformaldehyde (Sigma-Aldrich Chemie, Ger-
many) in 0.1M phosphate buffer (J.T Baker, NJ) (PB, Tecsiquim;
pH 7.4).
The brains were post-fixed with 10% formaldehyde (J.T
Baker, USA) for 24 h and embedded in paraffin (McCormick,
St. Louis, MO, USA). Sagittal brain slices (5µm) containing
the substantia nigra were obtained using a microtome (Ameri-
can Optical, model #680, clearence angle = 19◦) and mounted
on slides. For each group, sagittal brain slices containing
the substantia nigra were processed for immunohistochemistry
assays.
Protein Carbonyl Content
Carbonyl formation was assessed based on the formation of the
protein hydrazone by reaction with 2, 4-dinitrophenylhydrazine
(DNPH). Plasma from the rats was incubated overnight with 10%
streptomycin sulfate to remove nucleic acids and centrifuged at
21,000 g at 4◦C for 40min. The plasma samples were treated
with 10mM DNPH (in 2.5M HCl) for 1 h at room temperature;
10% trichloracetic acid was added, and the samples were cen-
trifuged at 2500 g at 4◦C for 10min. The pellets were washed
three times with ethanol:ethyl acetate (1:1), dissolved with 6M
guanidine hydrochloride (in 20mM phosphate buffer, pH 7.4),
incubated for 10min at 37◦C, and centrifuged at 5000 g at 4◦C
for 3min to remove insoluble material. Absorbance was mea-
sured at 370 nm. The protein carbonyl content was expressed
as nmol carbonyl/mg protein using the molar absorption coef-
ficient of DNPH (22,000 M-1 cm-1). The total protein concen-
tration was obtained by comparison with the optical density at
280 nm of blank tubes prepared in parallel (only treated with
HCl) and a standard curve of bovine serum albumin (0.25–2
mg/mL) prepared in 6M guanidine-HCl.
Western Blot
The expression levels of Iba-1 and NFκB were analyzed by
gel electrophoresis and western blot. The tissue was homog-
enized, and 50µg of protein from each sample was boiled
and separated on a 10% SDS polyacrylamide gel for 45min.
For WB analysis, proteins were electrophoretically transferred
onto a PVDF membrane (Sigma-Aldrich). The membranes were
blocked with 5% fat-free milk in Tris buffer solution (TBS-T)
with 0.01% Tween 20 (TBS-T) (Sigma-Aldrich) for 2 h at 37◦C
to eliminate non-specific binding. After the blocking step, mem-
branes were incubated individually with the Iba-1 and NFκB
antibodies overnight under gentle shaking at 4◦C (Brinkmann
OrbMix 110, Brinkmann, Germany). Membranes were rinsed
three times with TBS-T, incubated for 2 h at room tempera-
ture (RT) in TBS-T containing the HRP-conjugated anti-rabbit
IgG secondary antibody diluted 1:10,000 with goat anti-rabbit
IgG conjugated to horseradish peroxidase (1:10,000) (sc-2004
Biotechnology, Santa Cruz, CA) for 1 h and then rinsed three
times with TBS-T. Immunoreactive bands were detected by
chemiluminescence (ECL; General Electric, Santa Clara, CA). For
densitometric analysis of Western blot images ImageJ software
was used.
Immunohistochemistry for cyt c, GFAP, Iba-1,
NFkB and COX-2
Monoclonal mouse anti-glial fibrillary acidic protein (GFAP)
for astrocytic cells and polyclonal mouse anti-ionized calcium-
binding adapter molecule 1 (Iba-1) antibodies were obtained
from Biocare. Rabbit polyclonal anti-cytochrome c, mouse poly-
clonal anti-nuclear factor kappa-B (NFκB) and rabbit polyclonal
anti-cyclooxygenase 2 (COX-2) were obtained from Santa Cruz
Biotechnology, CA, USA.
For each brain, sagittal sections containing the substantia
nigra were treated with a paraffin-removal and heat-retrieval
solution (Biocare Medical) and put into an electric pressure
cooker (Decloaking Chamber, Biocare Medical) for 5min. After
that, slides were washed with distilled water and treated with
3% hydrogen peroxide (diluted 1:5; Fisher Scientific) for 5min.
Then, sections were rinsed with distilled water, treated with a
blocking reagent (Background Sniper, 4plus Detection Compo-
nent, Biocare Medical) for 10min, washed with 0.1M phos-
phate saline buffer (PBS; pH 7.4; Merck), and incubated for
12 h at 4◦C with anti-cyt c (diluted 1:200), anti-GFAP (diluted
1:200), anti-Iba-1(diluted 1:300), anti-NFkB (diluted 1:200, Santa
Cruz Biotechnology) and anti-COX-2 (diluted 1:200). Sections
were rinsed with PBS and treated with biotinylated secondary
antibody (Universal Link, Biocare Medical) for 1 h. After being
washed with PBS, treated with streptavidin-enzyme conjugates (4
plus the detection component streptavidin-HRP, Biocare Medi-
cal) for 30min, and washed again with PBS, the bounded anti-
body was visualized using 3, 3-diaminobenzidine (DAB Substrate
Kit, ScyTek) as the chromogen. The slices were washed in
distilled water and counterstained with hematoxylin-buffered
solution. Representative brain sections from each group were
processed in parallel after coverslipping with Permount. The sec-
tions were then examined with a BX41 Olympus Microscope and
photographed with an Evolution-QImagin Digital Camera Kit
(MediaCybernetics).
Number of Cells in the Substantia Nigra
Six animals from each experimental and control group were ana-
lyzed. The number of immunoreactive cells in the substantia
nigra was counted using six representative brain sections from
each group for each antibody. For each group, the total number of
immunoreactive cells per microscopic field at 40X magnification
was counted. The microscopic field had an area of 30,000µm2
and was 5-µm thick). The number of cells per field was counted,
and the median number of cells was calculated.
Statistics
Protein peroxidation levels and cell number were expressed as
medians and analyzed with Kruskal–Wallis and Mann–Whitney
U-tests.
Results
To evaluate the oxidative injury caused by ozone exposure, we
measured protein carbonyl content in the plasma of rats. The
protein carbonyl formation in the plasma of rats increased pro-
gressively with the time of exposure to ozone in the 30- and
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FIGURE 1 | Protein carbonyl levels in the plasma of rats exposed to
ozone. The ordinate represents carbonyl group levels, expressed as nmol
DNPH/mg of plasma protein (mean). The treatments are indicated under each
bar. *Significantly different from the control group (vs. 30, 60, and 90 days of
ozone exposure; P < 0.05).
90-day treatment groups. The Kruskal–Wallis test showed sig-
nificant between-group differences in the amount of protein oxi-
dized (P < 0.0005). The Mann-Whitney U-test showed sig-
nificant differences between the control group and the 30-day
(2.43 ± 0.18 nmol DNPH/mg protein) (P < 0.05), 60-day (3.47
± 2 nmol/mL) (P < 0.05) and 90-day (3.23 ± 1.007 nmol
DNPH/mg protein) (P < 0.05) ozone-exposed groups. Protein
carbonyl levels in the plasma progressively increased as a function
of the duration of exposure (Figure 1).
Immunohistochemistry
Cytochrome c immunohistochemistry
To determine whether cytochrome c was released from mito-
chondria within the cytoplasm of substantia nigra cells and to test
whether such release was modulated by levels of mitochondrial
oxidative stress after experimental ozone exposure, we performed
immunohistochemistry assays (2A; a. b, c, d, e, f). The median
number of cells that showed cytoplasmic immunoreactivity to
cytochrome c started to increase at 7 and 15 days. However, we
observed that cytochrome c translocated to the nucleus at 30 days
of exposure. In general, the median number of cells immunoreac-
tive for cytochrome c increased significantly in the 15-, 30-, 60-,
and 90-day exposure groups (P < 0.03) compared to the control
group (Figure 2B). Western blot analysis was performed; how-
ever there was no statistically significant difference between the
groups (data not shown).
GFAP immunohistochemistry
Western blot showed an increase of GFAP expression at 7, 15, 30,
and 60 days of ozone exposure (Figure 3A). Normal astrocytes
were observed in the GFAP immunohistochemistry in the control
group. In the groups exposed to ozone for 7 (2b), 15 (2c), and 30
days (2d), we detected an increase in the number of immunore-
active cells, and for the 30- and 60-day (2e) exposure groups,
the GFAP immunoreactivity levels in each cell increased. Partic-
ularly in the groups exposed to ozone for 30 and 60 days, GFAP
FIGURE 2 | Effect of ozone treatment on cytochrome c
immunoreactivity in the substantia nigra. (A) Light photomicrographs
show cytochrome c immunoreactivity in the substantia nigra of the rats treated
with air only (a), 7 days of ozone exposure (b), 15 days of ozone exposure (c),
30 days of ozone exposure (d), 60 days of ozone exposure (e), and 90 days of
ozone exposure (f). Arrows show cytochrome c immunoreactivity in normal
cells. 40X. We observed an increase in cytochrome c immunoreactivity and
nucleus translocation (arrows in c, d, and f). The graph shows the effect of
ozone treatment on the number of cytochrome c-positive cells in the
substantia nigra (B). The mean numbers of cytochrome c-positive cells are
depicted on the ordinate. The treatments are indicated under each bar (control
group and 7, 15, 30, 60, and 90 days of ozone exposure); n = 6 per group.
*P < 0.05.
increased in the processes of astrocytes. All astrocytes indicate
astroglial reactivity. In the substantia nigra of animals exposed
to 90 days of ozone, astrocytes showed morphological changes
(Figure 3B). The number of astrocytes in the substantia nigra
changed in the groups exposed to ozone for 15 (19 ± 0.6), 30
(20.75 ± 1.5), and 60 days (17 ± 0.6) compared to the control
group (13 ± 1) (P < 0.01). The groups exposed to ozone for 15,
30, and 60 days had significantly more astrocytes than the group
exposed to ozone for 90 days (P < 0.05) (Figure 3C).
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FIGURE 3 | Effect of ozone treatment on GFAP protein expression in
the substantia nigra. (A) Representative western blot of GFAP expression.
(B) Light photomicrographs showing GFAP immunoreactivity (arrows) in the
substantia nigra of the rats treated with air only (a), 7 days of ozone exposure
(b), 15 days of ozone exposure (c), 30 days of ozone exposure (d), 60 days of
ozone exposure (e), and 90 days of ozone exposure (f). Arrows show normal
GFAP. 40X. In the ozone treatment groups, we observed changes in the size of
astrocytes (c) and morphological changes. (C) The graph shows the effect of
ozone treatment on the number of GFAP-positive cells in the substantia nigra.
These changes were statistically significant for 15 and 30 days of treatment.
The mean numbers (±SE) of GFAP-positive cells are depicted on the ordinate.
The treatments are indicated under each bar (control group and 7, 15, 30, 60,
and 90 days of ozone exposure); n = 6 per group. *P < 0.05.
Microglial immunohistochemistry
Western blot showed an increase of GFAP expression at 60 and
90 days of ozone exposure (Figure 4A). Microglial immunoreac-
tivity for Iba-1 showed that the chronic oxidative stress induced
by ozone produced phenotypical changes in microglia in the sub-
stantia nigra (Figure 4B). We measured a decrease of resting
microglia beginning in the 7- and 15-day groups (b, c) and an
FIGURE 4 | Effect of ozone treatment on Iba-1 immunoreactivity in the
substantia nigra. (A) Representative western blot of the Iba-1 expression
pattern. (B) Light photomicrographs show Iba-1 immunoreactivity in the
substantia nigra of the rats treated with air only (a), 7 days of ozone exposure
(b), 15 days of ozone exposure (c), 30 days of ozone exposure (d), 60 days of
ozone exposure (e), and 90 days of ozone exposure (f). Arrows show microglia
with normal Iba-1 immunoreactivity. 40x. We observed a phenotypical change
in the microglia with ozone treatment. (B) The graph shows the effect of ozone
treatment on the number of Iba-1-positive microglia in the substantia nigra (C).
The mean numbers (±SE) of Iba-1-positive microglia are depicted on the
ordinate. The treatments are indicated under each bar (control group and 7,
15, 30, 60, and 90 days of ozone exposure); n = 6 per group. *P < 0.05.
increase of activated and phagocytic microglia in the 60-day
group (e) (P < 0.05). However, the number of microglial cells
increased at 60 days of ozone exposure and decreased at 90 days
(Figure 4C).
NFkB immunohistochemistry
NFkB expression pattern was observed by western blot and
showed an increase in protein expression in the 60-day exposure
group and a decrease in the 90-day group with respect to the
control group expression at 15 and 60 days of ozone expo-
sure (Figure 5A). NFκB immunoreactivity (Figure 5B) showed
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FIGURE 5 | Effect of ozone treatment on NFkB immunoreactivity in the
substantia nigra. (A) Representative western blot for NFkB expression. (B)
Light photomicrographs show NFkB immunoreactivity in the substantia nigra
of the rats treated with air only (a), 7 days of ozone exposure (b), 15 days of
ozone exposure (c), 30 days of ozone exposure (d), 60 days of ozone
exposure (e), and 90 days of ozone exposure (f). Arrows show cells with
normal NFkB immunoreactivity. 40X. We observed an increase of
immunoreactivity in the cell nucleus with ozone treatment and a decrease in
the number of NFkB-positive cells in (e) and (f). (C) The graph shows the effect
of ozone treatment on the number of NFkB-positive cells in the substantia
nigra. The mean numbers (±SE) of NFkB-positive cells are depicted on the
ordinate. The treatments are indicated under each bar (control group and 7,
15, 30, 60, and 90 days of ozone exposure); n = 6 per group. *P < 0.05.
an increase in nuclear translocation at 7 (b), 15 (c), and 30 days
(d) of ozone exposure and decreases at 60 (e) and 90 (f) days The
median number of cells in the substantia nigra with a nucleus
immunoreactive for NFκB increased significantly (P < 0.003)
in the groups exposed to ozone for 7, 15, and 30 days com-
pared to the control group (Figure 5C). Compared to the 15-day
group (P < 0.05), a significant decrease in the number of neu-
rons was also found in the groups exposed to ozone for 60 and
90 days (Figure 5C). Data are presented as the mean of three
independent experiments.
COX-2 immunohistochemistry
Low immunoreactivity for COX-2 was found in the substantia
nigra of the control group. In the groups exposed to ozone for
7, 15, and 30 days, immunoreactivity for this enzyme increased.
FIGURE 6 | Effect of ozone treatment on COX-2 expression in the
substantia nigra. (A) Light photomicrographs show COX-2 immunoreactivity
in the substantia nigra of the rats treated with air only (a), 7 days of ozone
exposure (b), 15 days of ozone exposure (c), 30 days of ozone exposure (d), 60
days of ozone exposure (e), and 90 days of ozone exposure (f). Arrows show
cells with normal COX-2 immunoreactivity. 40x. We observed an increase of
cellular immunoreactivity in the rats treated with ozone. (B) The graph shows
the effect of ozone treatment on the number of COX-2-positive cells in the
substantia nigra. Mean numbers (±SE) of COX-2-positive cells are depicted on
the ordinate. The treatments are indicated under each bar (control group and
7, 15, 30, 60, and 90 days of ozone exposure); n = 6 per group. *P < 0.05.
In the groups exposed for 60 and 90 days, marked immunoreac-
tivity and a qualitative change in cell morphology were observed
(Figure 6A). The number of substantia nigra cells per field that
were immunoreactive for COX-2 (Figure 6B) was significantly
different in the groups exposed to ozone for 7 (b), 15 (c), 30
(d), 60 (e), and 90 days (f) (P < 0.05) compared to the control
group (a).
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Discussion
Previous results from our laboratory have shown that acute
ozone exposure (0.8 ppm) causes oxidative stress, as shown by an
increase in lipid peroxidation levels in different brain structures
(Rivas-Arancibia et al., 2003, 2013; Angoa-Pérez et al., 2006).
In addition to oxidative stress, acute ozone exposure causes
neuronal morphological and ultrastructural changes (Rivas-
Arancibia et al., 2013). Our previous results in this animal
model have shown that groups chronically exposed to ozone for
7 and 15 days (0.25 ppm) recover from the damage 30 days
after the ozone exposure. After 30 days of ozone exposure, the
neurodegenerative process is irreversible and the brains of the
rats show an increase of cellular and structural damage over
time (4, 18).
In this study, rats were chronically exposed to 0.25 ppm
because the transient effects of ozone are more closely related to
accumulative daily exposure than to 1-h peak concentrations.
These results show the potential effect of ozone-based envi-
ronmental pollution in the brain. Previous results have shown
alterations in exploratory and freezing behaviors, which were
detected in groups exposed to ozone compared to the con-
trol group (Dorado-Martínez et al., 2001; Rivas-Arancibia et al.,
2003); this erratic behavior could be a consequence of the
dopaminergic neuronal damage in the substantia nigra and stria-
tum (Santiago-López et al., 2010). In this model, this damage
is caused by a chronic state of oxidative stress, as indicated by
the increase in protein oxidation levels in the groups exposed to
ozone (Figure 1). Altered levels of oxidized proteins affect cor-
rect cell functioning. In this way, one of these altered proteins
could be dopamine. Dopamine has an oxidative metabolism that
makes dopaminergic neurons and their fibers especially sensitive
to oxidative stress. A chronic state of oxidative stress induced by
ozone exposure causes dopamine oxidation, produces dopamine
quinones in the striatum, and increases the oxidative process as
we have previously shown (Rivas-Arancibia et al., 2003; Santiago-
López et al., 2010). Dopamine and dopamine quinones may
react with cysteine, producing free radicals and dehydrobenzoth-
iazines and depleting antioxidant defenses (Rivas-Arancibia et al.,
2004). This process can contribute to progressive cell death, as
cytochrome c release from mitochondria occurs in this model
(Figure 2) (Rodríguez-Martínez et al., 2013).
In this study, we show that for 15–90 days of ozone treat-
ment, there was a translocation of cytochrome c from mito-
chondria to the cytosol. The cytochrome c translocation could
be correlated with the mitochondrial protein oxidation previ-
ously reported by Rodríguez-Martínez et al. (2013), suggesting
that the release of cytochrome c after ozone treatment is mediated
in part by mitochondrial oxidative stress-dependent mechanisms
(Fujimura et al., 1998, 1999; Ramsden et al., 2001).
Previous data has supported the role of cytochrome c release
as the initiator of themitochondrial apoptotic pathway (Fujimura
et al., 2000; Sugawara et al., 2000). The release of cytochrome c
results in additional ROS production through inhibition of the
respiratory chain (Li et al., 1997). These events promote a vicious
cycle of increased cytochrome c release followed by increased
mitochondrial ROS production, which may be maintained.
Finally, Liu et al. (1997) and Lewén (2001) have demonstrated
that severe injury with marked ROS stress leads to necrotic cell
death, whereas milder ROS stress activates apoptotic pathways.
Our results suggest that cytochrome c release could lead to overall
cell death or apoptosis. However, which mechanism is activated
in our model remains to be elucidated.
In another way, GFAP has been widely used is as a molec-
ular marker for gliosis. GFAP is an intermediate filament pro-
tein that mediates the acquisition of the fibrotic phenotype of
reactive astrocytes. There are several studies that have shown
an increase in its expression during aging and its overexpres-
sion in oxidative stress states (Morgan, 1997; Cai et al., 1998;
Lewén, 2001). Our results show that oxidative stress produces
morphological alterations and cell death, causing an increase of
GFAP expression from 15 until 90 days of treatment. A significant
increase in the number of GFAP cells in the substantia nigra was
also found after 15 and 30 days of treatment, but this response
decreased in the 60- and 90-day groups. There are many reports
that have demonstrated phenotypic changes in astrocytes accom-
panied by the increase of proinflammatory cytokines and a loss of
the microglial neuroprotective function in different neurodegen-
erative diseases (Tacconi et al., 1991; Choi and Yu, 1995; Zhang
et al., 2005; Garden and Möller, 2006; Gerhard et al., 2006; Solito
and Sastre, 2012). However, more studies are needed to demon-
strate the microglia loss function in this oxidative stress model.
Previously, we have reported that there are irreversible changes
and neurodegenerative processes that start after 30 days of ozone
exposure. Therefore, we could suggest that this cellular response
has been inhibited by the oxidative stress state induced by ozone.
However, further studies are needed to probe this hypothesis.
The TH immunohistochemistry previously reported by our
group showed qualitative changes in neuronal shape and size,
the loss of dendrites, the presence of cytoplasmic vacuoles, dam-
age to the neuropil and significant decreases in the number of
neurons in the substantia nigra (Pereyra-Muñoz et al., 2006).
The neurodegenerative process has been linked to inflammatory
processes, as we have seen in astrocytic changes (Figures 3, 4).
Together with the increase in Iba-1 protein at 60 and 90
days of exposure (Figure 4), the phenotypical changes in the
microglia that transitioned from resting microglia to activated
and phagocytic microglia suggests an alteration of the activation
of immune responses induced by ozone exposure. There are dif-
ferent immune responses within different cell types, especially
with respect to the microglia and macrophages that may con-
tribute to inflammation and subsequent cell death. Moreover,
these changes are correlated with alterations in the number of
NFkB immunoreactive cells and NFkB protein expression level,
which was observed following 7–90 days of exposure (Figure 5).
Exposure to ozone causes oxidative stress, which triggers the
inflammatory response and there are many pathways by which
inflammation is activated by reactive species (Choi and Yu, 1995;
Vijitruth et al., 2006; Orre et al., 2014). One of these pathways
is the activation of membrane kinases that activate NFkB, which
causes an increase in the production of inflammatory cytokines.
NFkB is a transcription factor thought to be regulated by
oxidative stress and has been recognized for its role in the induc-
tion of inflammatory responses (Schreibelt Kooij et al., 2007).
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However, this activation of NFkB can result in enhanced de novo
synthesis of proteins that both confer protection and cause death
(Schreibelt Kooij et al., 2007; Orre et al., 2014). In this study, we
observed a large number of cells immunoreactive for NFkB as a
result of treatment; however, the number decreased after 60 and
90 days of treatment. Based on these results, we can suggest that
compared to the control, a large number of cells respond to ozone
treatment. We can also suggest that altered immune responses
are activated by oxidative stress. These immune responses could
trigger pro-inflammatory processes activated by NFkB through
the non-canonical pathway (Helenius, 1996; Morgan and Liu,
2010). The increase in COX-2 immunoreactivity supports this
hypothesis (Figure 6).
Oxidative stress caused by low-dose exposure to ozone acti-
vates COX-2, which is involved in the production of pro-
inflammatory prostaglandins (Martínez-Canabal et al., 2008).
This response can be activated by the non-canonical NFkB path-
way (Orre et al., 2014). These results suggest that the oxidative
stress itself is activating inflammatory responses when there are
alterations produced by chronic exposure to ozone, and this type
of response could be involved in cell death mechanisms. How-
ever, more mechanistic studies are needed to demonstrate the
importance of these alterations and what type of responses are
activated by NFkB.
The physiological inflammatory response is an auto-limited
response and is evoked to repair an altered microenvironment.
This regulated response was initiated after 7 and 15 days of ozone
exposure in this experiment, but when the neurodegenerative
process is irreversible (30, 60, and 90 days of ozone exposure),
dysregulation of the inflammatory response occurs, which alters
the blood-brain barrier (Rivas-Arancibia et al., 2013), triggering
all inflammatory processes. It has been suggested that the inflam-
matory response could cause alterations in the blood-brain bar-
rier in the zone of injury (Morgan and Liu, 2010). During this
process, there is a loss of endothelial cell function and capillary
changes in the structures affected (Rivas-Arancibia et al., 2013).
In addition to the alterations of the tight junctions of endothe-
lial cells, pericytes and the ends of the astrocyte terminals are
altered as well (Schreibelt Kooij et al., 2007). These alterations
cause the barrier to be more permeable and less selective, allow-
ing substances that require transporters to cross the barrier more
easily (Rivas-Arancibia et al., 2013).When a brain-damaging pro-
cess is accompanied by inflammation, substances and cells are
found that are not normally present in these sites. This hypothe-
sis has been used to explain the progressive damage in Parkinson’s
disease (Morgan and Liu, 2010; Przedborski, 2010).
The presence of dopamine quinones in the substantia nigra
and striatum in humans has been reported (Gerhard et al., 2006).
Dopamine oxidation, inflammation, oxidative stress, and dys-
function of the ubiquitin proteasome system are factors that, as a
whole, contribute to the pathogenesis and progression of Parkin-
son’s disease (Helenius, 1996; Asanuma et al., 2004; Martínez-
Canabal et al., 2008; Miyazaki and Asanuma, 2008).
In conclusion, our model shows that ozone exposure induces
oxidative stress. The state of chronic oxidative stress could itself
generate progressive cell death in the substantia nigra depend-
ing on the duration of ozone exposure. This process occurred
together with a dysregulation of the inflammatory response,
dopamine oxidation, and cell death, producing a vicious cycle
of the generation of an extensive oxidative stress state and the
incapacity of antioxidant systems to counteract it, as could be
happening in Parkinson’s disease.
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